Mankind Pharma Experiences Revision in Stock Score Amid Market Fluctuations in January 2025

Mankind Pharma, a notable entity in the pharmaceuticals and drugs sector, has recently undergone an adjustment in its evaluation. On January 10, 2025, the stock experienced a decline of 3.41%, contributing to a downward trend that has seen it lose 5.95% over the past three days. On this day, Mankind Pharma reached an intraday low of Rs 2745, reflecting a decrease of 3.29%.
Despite these recent challenges, Mankind Pharma has demonstrated resilience over the past month, achieving a positive return of 3.39%. This performance stands in contrast to the broader market, as the Sensex experienced a decline of 5.16% during the same timeframe. The stock's moving averages indicate that it remains above the 50-day, 100-day, and 200-day averages, although it currently sits below the 5-day and 20-day moving averages.

In light of the current market dynamics, Mankind Pharma has been added to MarketsMOJO's list, underscoring its significance in the pharmaceutical landscape. As the industry continues to navigate fluctuations, Mankind Pharma's stock remains a focal point for investors looking for stability in a challenging environment.